Sigma Planning Corp Sells 710 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Sigma Planning Corp trimmed its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 10.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,373 shares of the financial services provider’s stock after selling 710 shares during the quarter. Sigma Planning Corp’s holdings in iShares Biotechnology ETF were worth $843,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. Darwin Wealth Management LLC acquired a new position in iShares Biotechnology ETF in the third quarter valued at about $29,000. Highline Wealth Partners LLC bought a new position in shares of iShares Biotechnology ETF in the third quarter valued at approximately $30,000. HHM Wealth Advisors LLC boosted its holdings in shares of iShares Biotechnology ETF by 200.0% in the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 150 shares in the last quarter. Newbridge Financial Services Group Inc. bought a new stake in iShares Biotechnology ETF during the 4th quarter worth approximately $33,000. Finally, Hager Investment Management Services LLC acquired a new stake in iShares Biotechnology ETF during the 4th quarter valued at $34,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $137.86 on Wednesday. The business’s fifty day moving average is $135.64 and its two-hundred day moving average is $140.74. iShares Biotechnology ETF has a 52 week low of $123.60 and a 52 week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.